Mode
Text Size
Log in / Sign up
N/A Completed N=1,665 Randomized Other

Randomized Trial of Telemedicine for Diabetes Care

Source: ClinicalTrials.gov NCT00271739 ↗
Enrolled (actual)
1,665
Serious AEs
0.0%
Results posted
Aug 2011
Primary outcomePrimary: Hemoglobin A1c Levels — 7.09; 7.38 A1c percentage

Summary

The IDEATel study is a multicenter randomized controlled trial to evaluate the efficacy, acceptability, and cost-effectiveness of telemedicine case management to provide diabetes care to elderly Medicare beneficiaries residing in medically underserved areas of New York State.

Outcome Measures

OutcomeResultp-value
PRIMARY
Hemoglobin A1c Levels
7.09; 7.38 —
PRIMARY
Blood Pressure Levels
135.83; 140.15 —
PRIMARY
Serum Lipids Levels; Low-density Lipoprotein (LDL)-Cholesterol
91.13; 94.97 —

Eligibility Criteria

Inclusion Criteria

  • Age 55 years or greater
  • Being a current Medicare beneficiary (verified by the Centers for Medicare and Medicaid Services)
  • Having diabetes mellitus as defined by a physician's diagnosis and being on treatment with diet, an oral hypoglycemic agent, or insulin
  • Residence in a federally designated medically underserved area (either of two federal designations, Medically Underserved Area [MUA] or Health Manpower Shortage Area [HPSA]) in New York Sate
  • Fluency in either English or Spanish

Exclusion Criteria

  • Moderate or severe cognitive, visual, or physical impairment
  • The presence of severe co-morbid disease.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00271739). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search